Nanalysis Scientific Corp Stock Performance
| NSCIF Stock | USD 0.24 0.03 11.11% |
The company secures a Beta (Market Risk) of -0.0895, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Nanalysis Scientific are expected to decrease at a much lower rate. During the bear market, Nanalysis Scientific is likely to outperform the market. At this point, Nanalysis Scientific Corp has a negative expected return of -0.17%. Please make sure to verify Nanalysis Scientific's value at risk and the relationship between the kurtosis and market facilitation index , to decide if Nanalysis Scientific Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Nanalysis Scientific Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's forward indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
| Begin Period Cash Flow | 3.2 M | |
| Total Cashflows From Investing Activities | -3.3 M |
Nanalysis |
Nanalysis Scientific Relative Risk vs. Return Landscape
If you would invest 29.00 in Nanalysis Scientific Corp on August 28, 2024 and sell it today you would lose (5.00) from holding Nanalysis Scientific Corp or give up 17.24% of portfolio value over 90 days. Nanalysis Scientific Corp is currently producing negative expected returns and takes up 5.1598% volatility of returns over 90 trading days. Put another way, 45% of traded otc stocks are less volatile than Nanalysis, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Nanalysis Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nanalysis Scientific's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Nanalysis Scientific Corp, and traders can use it to determine the average amount a Nanalysis Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.033
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NSCIF |
Estimated Market Risk
| 5.16 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nanalysis Scientific is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nanalysis Scientific by adding Nanalysis Scientific to a well-diversified portfolio.
Nanalysis Scientific Fundamentals Growth
Nanalysis OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Nanalysis Scientific, and Nanalysis Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nanalysis OTC Stock performance.
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0726 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.28) % | |||
| Current Valuation | 52.82 M | |||
| Shares Outstanding | 94.22 M | |||
| Price To Book | 1.91 X | |||
| Price To Sales | 2.30 X | |||
| Revenue | 16.04 M | |||
| EBITDA | 1.38 M | |||
| Cash And Equivalents | 12.28 M | |||
| Cash Per Share | 0.13 X | |||
| Total Debt | 2.75 M | |||
| Debt To Equity | 0.16 % | |||
| Book Value Per Share | 0.39 X | |||
| Cash Flow From Operations | (1.2 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 37.79 M | |||
About Nanalysis Scientific Performance
By analyzing Nanalysis Scientific's fundamental ratios, stakeholders can gain valuable insights into Nanalysis Scientific's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nanalysis Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nanalysis Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance spectrometers and magnetic resonance imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It sells its products directly, as well as through a network of distributors worldwide. NANALYSIS SCIENTIFIC operates under Scientific Technical Instruments classification in the United States and is traded on OTC Exchange. It employs 107 people.Things to note about Nanalysis Scientific Corp performance evaluation
Checking the ongoing alerts about Nanalysis Scientific for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Nanalysis Scientific Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nanalysis Scientific generated a negative expected return over the last 90 days | |
| Nanalysis Scientific has high historical volatility and very poor performance | |
| Nanalysis Scientific has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 16.04 M. Net Loss for the year was (1.77 M) with profit before overhead, payroll, taxes, and interest of 10.24 M. | |
| Nanalysis Scientific Corp has accumulated about 12.28 M in cash with (1.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13. |
- Analyzing Nanalysis Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nanalysis Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Nanalysis Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nanalysis Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nanalysis Scientific's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Nanalysis Scientific's otc stock. These opinions can provide insight into Nanalysis Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nanalysis OTC Stock analysis
When running Nanalysis Scientific's price analysis, check to measure Nanalysis Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanalysis Scientific is operating at the current time. Most of Nanalysis Scientific's value examination focuses on studying past and present price action to predict the probability of Nanalysis Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanalysis Scientific's price. Additionally, you may evaluate how the addition of Nanalysis Scientific to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |